BLFS (BioLife Solutions Inc) מכפיל EV/Sales

BioLife Solutions, Inc. (BLFS) relies on its own proprietary formula synthesis with minimal external component sourcing. The EV/Sales trend filters out market noise, and the current value of 17721.45 determines this valuation level. BioLife Solutions, Inc. (BLFS) attracts rare biotechnologists to advance cryopreservation, implementing reusable containers to minimize plastic use and the carbon footprint in logistics.
BLFS (BioLife Solutions, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator determines the market value of a business relative to its operating revenues. The Enterprise Value-to-Revenue (EV/Revenue) ratio reflects the actual capitalization of assets, accounting for debt obligations. The calculation is based on the ratio of the company's total value to its annual turnover, excluding the influence of the borrowing structure. For BioLife Solutions, Inc. (BLFS), this allows for an assessment of the efficiency of scaling supplies within the gene therapy sector. An increase in this metric confirms market confidence in the high margins of new consumables.